FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, and concerns an agent applicable for treating various forms of oncological diseases.
EFFECT: agent shows higher efficacy and contains sodium dichloroacetate and theophylline in ratio 1:1 to 10:1 as active ingredients.
9 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARAMCEUTICAL COMPOSITION FOR TREATMENT OF ONCOLOGICAL DISEASES | 2012 |
|
RU2484814C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS OF PROSTATE GLANDS | 2015 |
|
RU2589266C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS | 2019 |
|
RU2710273C1 |
| METHOD FOR PROCESSING TUMOUR CELLS | 2016 |
|
RU2632429C1 |
| METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
| AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
| METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
| STABLE PHARMACEUTICAL COMPOSITION BASED ON ACTINOMYCIN D FOR INJECTIONS | 2014 |
|
RU2587716C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING BREAST CANCER | 2015 |
|
RU2581022C1 |
| METHOD OF TREATING FOCAL AND CAVITARY CHANGES IN LUNGS OF POST-COVID ETIOLOGY | 2023 |
|
RU2809304C1 |
Authors
Dates
2012-10-10—Published
2011-06-08—Filed